Home › Compare › PXSTF vs ABBV
PXSTF yields 2000.00% · ABBV yields 3.06%● Live data
📍 PXSTF pulled ahead of the other in Year 1
Combined, PXSTF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PXSTF + ABBV for your $10,000?
Phoenix Media Investment (Holdings) Limited, an investment holding company, provides satellite television broadcasting services in the People's Republic of China and internationally. The company operates through five segments: Television Broadcasting, Internet Media, Outdoor Media, Real Estate, and Other Activities. The Television Broadcasting segment engages in broadcasting television programs and commercials; and provision of promotion activities through the operation of Phoenix Chinese and Phoenix InfoNews channels, as well as Phoenix Movies, Phoenix North America Chinese, Phoenix Chinese News and Entertainment, Phoenix Hong Kong, and other channels. The Internet Media segment offers website portal and value-added telecommunication services. The Outdoor Media segment provides outdoor advertising services. The Real Estate segment is involved in the property development and investment activities. The Other Activities segment offers program production and ancillary services, merchandising services, magazine publication and distribution, and other related services. It also provides radio broadcasting; research and development; cultural development; software and games development; trademark and property holding; hotel management; publishing and distributing periodicals; technical and financial consulting; aircraft chartering; exhibition; education technology; programme production; real estate brokerage; mobile value-add; capital market; and management and related services. The company was founded in 1996 and is headquartered in Tai Po, Hong Kong.
Full PXSTF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.